Name | sodium,3-[(E)-3-anilino-3-oxoprop-1-enyl]-4,6-dichloro-1H-indole-2-carboxylate |
---|---|
Synonyms |
UNII-80W7787JVB
4,6-dichloro-3-((1E)-3-oxo-3-(phenylamino)-1-propenyl)-1H-indole-2-carboxylic acid sodium salt Gavestinel sodium |
Description | Gavestinel (GV 150526) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke[1]. |
---|---|
Related Catalog | |
Target |
pKi: 8.5 (NMDA receptor)[1] |
References |
Molecular Formula | C18H11Cl2N2NaO3 |
---|---|
Molecular Weight | 397.19 |
Exact Mass | 396.00400 |
PSA | 88.51000 |
LogP | 5.34680 |